Xcout Intel
Brenig Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Brenig Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Brenig Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Brenig Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. is a clinical-stage biotechnology and drug development company focused on advancing small-molecule therapies.
Brenig Therapeutics, Inc. at a glance
Brenig Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $30M in July 2024. Xcout tracks 2 named people at Brenig Therapeutics, Inc., including Megan McGill (Chief Executive Officer).
Brenig Therapeutics, Inc. leadership
- Megan McGillChief Executive Officer
- Iain DukesChairman of the Board
Brenig Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $30M | — | |
| Series A | $65M | 5 named | |
| — | Undisclosed | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Brenig Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Brenig Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
BreStem Therapeutics, Inc. is a clinical-stage biotechnology company located in Raleigh, North Carolina, focused on developing novel therapeutics to fight various diseases.
Life Sciences
Beren Therapeutics P.B.C. is a fully integrated biotechnology company headquartered in Thousand Oaks, California, that advances biology and chemistry to develop first-in-class therapeutics addressing the root causes of diseases.
Similar biotechnology company
Cadenza Bio, Inc. is a privately held preclinical biotechnology company founded in 2022 and headquartered in Oklahoma City, dedicated to developing novel, non-steroidal, highly selective small-molecule therapies.
Similar biotechnology company
Brenus Pharma is a pioneering clinical-stage biotech company headquartered in Clermont-Ferrand, France. The firm focuses on developing innovative immunotherapies aimed at preventing cancer recurrence and addressing solid tumors.
Biotech
Sharp Therapeutics Corp. is a preclinical-stage biotechnology and drug discovery company that develops small molecule therapies to treat genetic diseases and hereditary disorders. The company combines high-speed experimentation and computational methods to advance its drug discovery platform.
Similar biotechnology company
BridGene Biosciences, Inc. is a biotechnology company headquartered in San Jose, California, pioneering next-generation chemoproteomics through its IMTAC platform. The company is focused on discovering and developing innovative small molecule drugs for high-value targets.
Similar biotechnology company
Bolden Therapeutics, Inc. is a privately held biotechnology company founded in 2019 and headquartered in Providence, Rhode Island, with corporate office space in Boston, Massachusetts. The company is dedicated to developing first-in-class therapeutics.
Similar biotechnology company
Reglagene Holding, Inc. is a biotechnology company developing brain-penetrant oral therapies for central nervous system oncology. Its lead small molecule candidate, RGN6024, is designed to cross the blood-brain barrier and evade efflux pumps to treat primary tumors and brain metastases.
Similar biotechnology company
Halda Therapeutics is a life sciences and drug discovery company based in New Haven, Connecticut, focused on developing targeted therapeutics.
Similar biotechnology company
Kinaset Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel therapeutics.
Similar biotechnology company
Kenai Therapeutics is a clinical-stage biotechnology company headquartered in San Diego, California. The company pioneers next-generation therapeutic approaches by leveraging induced pluripotent stem cell (iPSC) technology.
Similar biotechnology company
Edison Oncology Holding Corp is a clinical-stage biopharmaceutical company that develops first-in-class, small-molecule, biomarker-driven therapies to target major cancer markets. The company identifies, acquires, and advances underdeveloped drug candidates to address critical unmet needs for cancer patients with specific genetic mutations.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Brenig Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Brenig Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →